期刊文献+

PPAR-γ激动剂抑制IFN-γ和TNF-α诱导的肾小管上皮细胞趋化因子表达 被引量:3

PPAR-γ agonist inhibits the expressions of chemokines induced by IFN-γ and TNF-α in renal tubular epithelial cells
下载PDF
导出
摘要 目的探讨过氧化物酶体增殖物激活受体γ(PPAR-γ)激动剂15-脱氧-12,14-前列腺素J2(15d-PGJ2)对IFN-γ和TNF-α共同诱导HK-2肾小管上皮细胞趋化因子表达的影响。方法在IFN-γ和TNF-α联合刺激HK-2细胞的同时加入不同浓度的15d-PGJ2共同作用48 h,用实时定量PCR(qRT-PCR)和ELISA分别检测CXCL9、CXCL10和CXCL11的mRNA表达和蛋白分泌水平。结果在HK-2细胞中,IFN-γ和TNF-α联合刺激能够诱导趋化因子CXCL9、CXCL10、CXCL11的mRNA表达和蛋白分泌;经不同浓度的15d-PGJ2干预后,CXCL9、CXCL10、CXCL11的mRNA表达和蛋白分泌均被抑制,在15d-PGJ2浓度为2.0 ng/mL时,15d-PGJ2对CXCL9、CXCL10、CXCL11的mRNA和蛋白分泌的影响最大,与IFN-γ联合TNF-α组(15d-PGJ2浓度为0 ng/mL)相比,CXCL9、CXCL10、CXCL11的mRNA分别下降76.8%、78.7%和81.9%,培养上清中趋化因子蛋白分泌分别下降66.9%、86.6%和39.9%,差异均有统计学意义(P<0.05)。结论 PPAR-γ激动剂可抑制IFN-γ和TNF-α联合作用诱导的肾小管上皮细胞趋化因子CXCL9、CXCL10和CXCL11表达。 Objective To investigate the effect of peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist 15d-PGJ2 on the expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells (HK-2) stimulated by interferon-), (IFN-γ) plus tumor necrosis factor-α (TNF-α). Methods HK-2 cells were stimulated with IFN-γ plus TNF-α only, or incubated with 15d-PGJ2 for48 hours. CXCL9, CXCL10 and CXCL11 expressions were determined by real-time quantitative PCR (qRT-PCR) and ELISA. Results IFN-γ plus TNF-α increased mRNA and protein expressions of CXCLg, CXCL10 and CXCL11 in HK-2 cells. PPAR-γ agonist 15d-PGJ2 inhibited the expressions of CXCL9, CXCL10 and CXCL11 in IFN-γ combined with TNF-α-induced HK-2 cells. Compared with the IFN-γ plus TNF-α group (untreated with 15d-PGJ2), the CXCL9, CXCL10 and CXCL11 were depressed by 76.8%, 78.7% and 81.9% at mRNA level and 66.9%, 86.6% and 39.9% at protein level in 2.0 ng/mL 15d-PGJ2-treated HK-2 cells, respectively ( P 〈 0.05). Conduslon PPAR-γ agonist 15d-PGJ2 could inhibit CXCL9, CXCL10 and CXCL11 production induced by IFN-γ combined with TNF-α in HK-2 cells.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2014年第7期673-676,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 福建省自然科学基金(2013J01323) 福建省医学创新课题(2011-CX-28) 福建省教育厅课题(JB11066) 福建中医药大学校管课题(XB2011020)
关键词 过氧化物酶体增殖物激活受体Γ 趋化因子 人肾小管上皮细胞 细胞因子 peroxisome proliferator-activated receptor-α chemokine renal tubular epithelial cells cytokine
  • 相关文献

参考文献14

  • 1Groom JR, Luster AD. CXCR3 in T cell function [ J ]. Exp Cell Res, 2011, 317(5) : 620 -631.
  • 2Lo DJ, Weaver TA, Kleiner DE, et al. Chemokines and their receptors in human renal allotransplantation [ J]. Transplantation, 2011, 91(1) : 70 -77.
  • 3Romagnani P, Crescioli C. CXCL10: a candidate biomarker in transplantation[J]. Clin Chim Acta, 2012, 413 (17/18) : 1364 - 1373.
  • 4Huang H, Xu X, Yao C, et al. Sermn levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation [ J ]. Mol Med Rep, 2014, 9(1) : 45 -50.
  • 5Han Z, Zhu T, Liu X, et al. 15-deoxy-A12, 14 -prostaglandin J2 reduces recruitment of bone man, w-derived monocyte/macrophages in chronic liver injury in mice [ J ]. Hepatology, 2012, 56 ( 1 ) : 350 - 360.
  • 6Crescioli C, Cosmi L, Borgogni E, et al. Methimazole inhibits CXC chemokine ligand 10 secretion in human thyroeytes [ J ]. J Endoerinol, 2007, 195( 1 ) : 145 - 155.
  • 7Antonelli A, Ferrari SM, Maneusi C, et al. Interferon-or, -13 and -γ induce CXCLll secretion in human thyrocytes: Modulation by peroxisome proliferator-activated receptor γ agonists [ J ]. Inmmnobiolo, 2013, 218(5) : 690 -695.
  • 8AntoneUi A, Fermri SM, Fraseerra S, et al. Peroxisome proliferator- activated receptor-ct agonists modulate CXCL9 and CXCL11 chemokines in Graves' ophthalmopathy fibroblasts and preadipocytes [J]. Mol Cell Endocrinol, 2012, 349(2) : 255 -261.
  • 9Lu Y, Zhou Q, Zhong F, et al. 15-Deoxy-A( 12, 14)-prostaglandin J (2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells[J]. Nephron Exp Nephrol, 2013, 123 (1/2) : 1 - 10.
  • 10Fogo AB. PPARγ and chronic kidney disease[ J]. Pediatr Nephrol, 2011, 26(3) : 347 -351.

二级参考文献11

  • 1Nguan CY,Du C. Renal tubular epithelial cells as immunoregulatory cells in renal allograft rejection[J].Transportation Reviews,2009,(03):129-138.
  • 2Groom JR,Luster AD. CXCR3 in T cell function[J].Experimental Cell Research,2011,(05):620-631.
  • 3O' Boyle G,Ali S,Kirby JA. Chemokines in transplantation:what can atypical receptors teach us about anti-inflammatory therapy[J].Transportation Reviews,2011,(04):136-144.
  • 4Romagnani P,Crescioli C. CXCL10:A candidate biomarker in transplantation[J].Clinica Chimica Acta,2012,(17-18):1364-1373.
  • 5Lo DJ,Weaver TA,Kleiner DE. Chemokines and their receptors in human renal allotransplantation[J].Transplantation,2011,(01):70-77.
  • 6Inston N,Drayson M,Ready A. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation[J].Experimental and Clinical Transplantation,2007,(02):638-642.
  • 7Lazzeri E,Rotondi M,Mazzinghi B. High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy[J].Transplantation,2005,(09):1215-1220.
  • 8Thorburn E,Kolesar L,Brabcova E. CXC and CC chemokines induced in human renal epithelial cells by inflammatory cytokines[J].Acta Pathologica,Microbiologica Et Immunologica Scandinavica,2009,(07):477-487.
  • 9Cockwell P,Calderwood JW,Brooks CJ. Chemoattraction ofT cells expressing CCR5,CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines[J].Nephrology Dialysis Transplantation,2002,(05):734-744.
  • 10Rosenblum JM,Zhang QW,Siu G. CXCR3 antagonism impairs the development of donor-reactive,IFN-gamma-producing effectors and prolongs allograft survival[J].Transplantation,2009,(03):360-369.doi:10.1097/TP.0b013e31819574e9.

共引文献10

同被引文献40

  • 1Wei JF,Zheng SS. NF-kappa B in allograft rejection[J]. Hepatobiliary Pancreat Dis Int, 2003,2 (2) : 180-183.
  • 2Jia RP, Zhu JG, Wu JP, et al. Experimental study on ear- ly protective effect of ischemic preconditioning on rat kidney graft [J ]. Transplant Proc, 2009,41 ( 1 ) : 69-72.
  • 3Kanda N,Watanabe S. Prolactin enhances interferon-gam- ma-induced production of CXC ligand 9 (CXCL9),CX- CL10,and CXCLll in human keratinocytes[J]. En- docrindogy, 2007,148 (5) : 2317-2325.
  • 4Ferrari SM, Fallahi P,Vita R, et al. Peroxisome prolifera- tor-activated receptor-'y in thyroid autoimmunity[J]. PPAR Res,2015,2015:232818.
  • 5Ferrari SM,Antonelli A, Di Domenicantonio A, et al. Modu- latory effects of peroxisome proliferator-activated recep- tor-"/ on CXCR3 chemokines[J]. Recent Pat Inflamm Al- lergy Drug Diseov,2014,8(2) : 132-138.
  • 6Kiss E, Popovic ZV, Bedke J, et al. Peroxisome proliferator- activated receptor (PPAR)gamma can inhibit chronic re- nal allograft damage [J]. Am J Pathol,2010, 176 (5) : 2150-2162.
  • 7Feng Y,Cai ZR,Tang Y,et al. TLR4/NF-KB signaling pathway-mediated and oxLDL-induced up-regulation ofLOX-1 ,MCP-1 ,and VCAM-1 expressions in human um- bilical vein endothelial cells[J]. Genet Mol Res,2014, 13 ( 1 ) : 680-695.
  • 8Inston N,Drayson M,Ready A,et al. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation [J]. Exp Clin Transplant, 2007,5 (2) : 638-642.
  • 9Miiller M,Carter S,Hofer MJ,et al. Review:the chemokine receptor CXCR3 and its ligands CXCL9,CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conun- drum[J]. Neuropathol Appl Neuro biol,2010,36 (5): 368-387.
  • 10Du S,Hiramatsu N,Hayakawa K,et al. Suppression of NF- kappaB by cyclosporin a and tacrolimus (FK506) via in- duction of the C/EBP family:implica tion for unfolded protein response[J]. J Immunol,2009,182(11) :7201-7211.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部